|
|
Join over 800 Attendees from over 280 Organizations at the 25th Anniversary Pharmaceutical & Medical Device Ethics and Compliance Congress
|
- A Hybrid Onsite Conference and Internet Event
- The Leading Forum on Pharmaceutical and Medical Device Ethics and Compliance Issues
- Sponsored by Pharmaceutical Compliance Forum
- Media Partner: Policy & Medicine
- October 28-30, 2024
- Grand Hyatt Washington
- Washington, DC
- www.PharmaCongress.com
PRESS RELEASE
Phone: 800-503-7419
Email: reginfo@hcconferences.com
Website: www.PharmaCongress.com |
|
FEATURING ANNUAL OIG KEYNOTE ADDRESS BY
|
Mary E. Riordan, JD
Senior Counsel to the Inspector General, HHS Inspector General, Washington, DC
|
|
UPDATED AGENDA AVAILABLE
|
Click here for updated Agenda.
|
|
|
JOIN OVER 800 ATTENDEES FOR THE FOLLOWING OVER 280 ORGANIZATIONS
|
Abbott
AbbVie
AdvaMed
Alanda Software
Alexion, Astrazeneca Rare Disease
Alnylam
America’s Physician Groups
Amgen
Amplity Health
Ankura
Apellis
Apotex
Arnold & Porter
Arrowhead
Arthrex
Ascendis
ASCOM- Asociación Española de Compliance
Asensus Surgical
Astellas
AstraZeneca
Aurobindo Pharma USA
Avadel CNS
AVEO
Avita Medical
Axiom
Axonics
Azurity
B. Braun Medical
Baker Tilly
Bausch + Lomb
Bayer Healthcare
BDO
Beam Therapeutics
BeiGene
Berkle Consulting
Biocryst
Biogen
BiolineRx USA
Biomarin
bioMerieux
Biotechnology Innovation Organization
Blue Earth Diagnostics
Blueprint Medicines Corporation
Boeing Global Services
Boston Consulting Group
Braeburn
Bristol Myers Squibb
Cencora
Chiesi USA
Choate Hall & Stewart
CIAO
Clarke Consulting
Clifford Chance
Clinical Education Alliance
CMP Pharma
Collegium
Compliance Group
Comply Latam
ConvaTec
Cook Group
Cordis
Corium
Covington & Burling
Covis
Cresen Solutions
Cromley Consulting
Cutting Edge Information
Cytokinetics
Daiichi Sankyo
Deehr Law
Deloitte
Dentsply Sirona
Dermavant Sciences
DLA Piper
Dovetail Consulting Group
Duane Morris
Edwards Lifesciences
Edwards Value Based Health
EFPIA
Eisai
Elevar Therapeutics
Eli Lilly
Elm Ridge Consulting
Emergent Biosolutions
Endo
Epikast
Epsilon Life Sciences
Epstein Becker Green
Ernst & Young
Esperion Therapeutics
ETHICS
Evommune
Exelixis
|
Ferring
Forchelli, Deegan, Terrana
Fortrea
Fresenius Kabi
Fresenius Medical Care
Fulcrum Therapeutics
G&M Health
Galderma Laboratories
Gardner Law
GE Healthcare Pharmaceutical Diagnostics
Gedeon Richter
Geeta Thakerar Consultancy Services
Genentech
Genmab
Geron Corporation
Gilead Sciences
Goodwin Law
Goodwin Procter
Gore Medical
GRAIL
Gregg Shapiro Law
Grifols
GSK
Haleon
Harmony Biosciences
Helio
Hogan Lovell
ICC
ICU Medical
IFPMA
Immunocore
Incyte
Indivior
Insmed
Insulet Corp
Invivyd
Ionis Pharmaceuticals
Ipsen
IQVIA
Jaguar Health
Jazz Pharmaceuticals
Johnson & Johnson
Johnson & Johnson Innovative Medicine
Kaleo
Karl Storz, US
Karuna
Karyopharm Therapeutics
Katherine Verdin Consulting
Kedrion Biopharma
King & Spalding
Knipper Health
Kohler Health Law
KPMG
Kramen Law
Kyowa Kirin
Latham & Watkins
Latham BioPharma Group
Learnings and Entertainments
Legend Biotech
Lexicon Pharmaceuticals
Lextegrity
Life Molecular Imaging
Lighthouse AI
LivaNova
LRN
Lundbeck
Madrigal
Major, Lindsey & Africa
Mallinckrodt
Manatt
Mayer Brown
McDermott Will & Emery
Mecomed
MediSpend
Medline Industries
MedPro Systems
MedTech Europe
Medtronic
MEK Consulting
Melling Voitishkin & Partners
Merck & Co
Merz Aesthetics
Mirum
Mitsubishi Tanabe Pharma America
Morgan, Lewis & Bockius
Neurocrine Biosciences
NewBridge
Nihon Kohden North America
Novartis
Novo Nordisk
Novocure
NXLevel Compliance
Office of Inspector General, US Department of Health and Human Services
|
Olympus Corporation Of The Americas
ONG SAME
Ono
Organogenesis
Organon
Otsuka
Pacira BioSciences
Paratek
Paul Hastings
Pfizer
Pharmaceutical Compliance Forum
Pharming Healthcare
Phathom
Philips North America
PhRMA
Porzio, Bromberg & Newman
Potomac River Partners
Potter and Murdock
PricewaterhouseCoopers
Protiviti
PTC Therapeutics
Puma Biotechnology
Purdue Pharma
Qordata
Queisser and Associates
Regeneron
ResEcon Life Sciences & Healthcare
Rethink Compliance
Rhythm
Rigel
RLDatix Life Sciences
Rocket Pharmaceuticals
Ropes & Gray
ROUTE 2
RXCompliance Report
Sage Therapeutics
Sanofi
Sapient
SciencesPo
Sentynl Therapeutics
SERB
Seton Hall University School of Law
Sheppard Mullin Richter & Hampton
Shionogi
Shire
Sidley Austin
Sight Sciences
Skadden, Arps, Slate, Meagher & Flom
Socrates Healthcare
Soleno Therapeutics
Spark Therapeutics
SpringWorks Therapeutics
Stemline Therapeutics
Strategic Versaility
Stryker
Sue Egan Associates
Sun Pharma
Syndax
Syneos Health
Takeda
Tandem Diabetes Care
Tarsus
TD International
Telix
Terumo BCT
Teva
TG Therapeutics
Theratechnologies
Theravance Biopharma
Third Wave Associates
Tolmar
Tolmar
Travere
TRESTLE Compliance
UCB
Ultragenyx
United Therapeutics
Urogen
US Attorney's Office, Massachusetts
US Department of Justice
US Food and Drug Administration
Veloxis
Vericel Corporation
VFB Associates
Vifor
W. L. Gore & Associates
West Pharmaceutical Services
Whistleblower Law Collaborative
Whitelaw Compliance Group
Zambon US
Zimmer Biomet, Americas
Zoetis
Zoll Medical Corporation
ZS
|
|
SAVE THE DATE FOR THE 25TH ANNIVERSARY GALA BANQUET
|
Capacity for the banquet will be limited. Registration opportunities for the banquet will be announce in late September.
|
|
WASHINGTON, DC USA -- PHARMA UPDATE NEWS SERVICE™ -- OCTOBER 17, 2024: We are pleased to announce that the Twenty-Fifth Pharmaceutical & Medical Device Ethics and Compliance Congress sponsored by the Pharmaceutical Compliance Forum (PCF) will be held at the Grand Hyatt Washington, Washington, DC on October 28-30, 2024. Attendees may attend either virtually online or in person. For the first time, onsite attendees will also enjoy both live and post-conference access to the Congress audio/video archive.
|
|
GOVERNMENT KEYNOTE SPEAKERS
|
Catherine (Katie) Gray, PharmD
Director, Office of Prescription Drug Promotion, US Food and Drug Administration, Baltimore, MD |
Mary E. Riordan, JD
Senior Counsel to the Inspector General, HHS Inspector General, Washington, DC |
Colin Huntley, JD
Deputy Director, Civil Division, Fraud Section, US Department of Justice, Washington, DC
|
Jacob Foster, JD
Principal Assistant Chief, Health Care Fraud Unit, Criminal Division, US Department of Justice, Washington, DC |
Charlene Fullmer, JD
Assistant U.S. Attorney, Deputy Chief Civil Division, US Attorney’s Office, Eastern District of Pennsylvania, US Department of Justice; Former Attorney Advisor, Federal Bureau of Investigation and US Department of Transportation, Philadelphia, PA
|
Ellen Bowden McIntyre, JD
Assistant US Attorney and Deputy Chief, Affirmative Civil Enforcement, US Attorney’s Office, Middle District of Tennessee, US Department of Justice; Recipient, Executive Office for US Attorney’s Directors Award, Nashville, TN |
Amanda Strachan, JD
Assistant US Attorney and Chief, Criminal Division, US Attorney’s Office for the District of Massachusetts, US Department of Justice; Recipient, 2 Attorney General’s Awards for Distinguished Service; Recognized as 2023 Most Outstanding AUSA, Boston, MA
|
|
|
KEYNOTE SPEAKERS
|
Susan Dentzer, MS
President and Chief Executive Officer, America's Physician Groups; Wrote and Hosted PBS documentary, Reinventing American Healthcare; Former Editor in Chief, Health Affairs; Former Health Correspondent, PBS NewsHour, Washington, DC |
Myrtle Potter
Board, Liberty Mutual, Guardant Health, Opentrons & Univ of Chicago; Former President and CEO, Sumitomo Pharma America & Chair, Sumitomo Pharma UK; Former CEO, Sumitovant Biopharma; Former Vant Operating Chair, Roivant; Former President, Commercial Operations, Genentech; Former President, Cardiovascular/Metabolics, BMS, Cambridge, MA |
Brent Saunders, MBA, JD
Chairman & Chief Executive Officer, Bausch + Lomb; Former Chair, President & CEO, Allergan; President & CEO, Actavis plc; President & CEO, Forest Laboratories; President, Global Consumer Healthcare; Schering-Plough; Co-founder, International Association of Privacy Professionals (IAPP) and Pharmaceutical Compliance Forum (PCF), Miami Beach, FL
|
|
|
NEW KEYNOTE SPEAKER FOR THE INDUSTRY-ONLY DAY
|
|
Al Lambert, JD
Vice President & Assistant General Counsel, Boeing Global Services, Arlington, VA |
|
|
|
ANNUAL UPDATES FROM ADVAMeD, PhRMA AND BIO
|
John Delacourt, JD
Deputy General Counsel, Biotechnology Innovation Organization; Former Chief Antitrust Counsel, Office of Policy Planning, Federal Trade Commission, Washington, DC |
Ida Nassar, JD
Vice President, Assistant General Counsel, Ethics & Compliance, AdvaMed; Former Senior Attorney, Office of Chief Counsel, Drug Enforcement Administration, Washington, DC |
Julie Ritchie Wagner, JD
Senior Assistant General Counsel, PhRMA; Former Senior Counsel, Office of Counsel to the Inspector General, US Department of Health and Human Services, Washington, DC
|
|
|
FEATURED FACULTY
|
Ted Acosta, MS, JD
Leader, Office of Strategic Relationships, EY; Former Global Life Sciences Leader for Fraud Investigation & Dispute Services, EY; Former Senior Counsel, Office of The Inspector General, US Department of Health and Human Services, New York, NY |
Frank Adamo, MS
Director Corporate Compliance and Ethics, Syneos Health; Former Senior Special Agent, Office of the Inspector General, US Department of Justice; Former Special Agent, Drug Enforcement Administration, Somerset, NJ |
Micah Ackerman, JD
Associate Director, Ethics and Compliance, Eisai Inc; Former Senior Compliance Manager, Pfizer, New York, NY
|
Peter Agnoletto, CPA
Compliance Officer, General Medicines and Consumer Health Care, Sanofi; Former CCO & Chief Audit Executive & ERM Leader, Par Pharma, Bridgewater, NJ |
David Amendola
Director, ResEcon Life Sciences & Healthcare; Former, Global Compliance Risk Evaluation and Management, ConvaTec, New York, NY |
William L. Aprea, JD
Senior Vice President, Legal and Interim Chief Compliance Officer, Phathom Pharmaceuticals, Florham Park, NJ
|
Deidre Arnold, JD
Vice President TR Strategy/US TTR Franchise, Commercial Legal, Alnylam Pharmaceuticals, Cambridge, MA |
Jill Atstupenas, JD
Director, Compliance Syndax Pharmaceuticals, Inc., Boston, MA |
Meredith S. Auten, JD
Partner, Morgan, Lewis & Bockius LLP; National Co-chair, ABA’s Criminal Justice Section White Collar Committee Qui Tam Subcommittee, Philadelphia, PA
|
Samantha Barrett Badlan, JD
Partner, Litigation & Enforcement Group, Ropes & Gray, Washington, DC |
Yogesh Bahl, MBA
Partner & Leader, Life Sciences & Healthcare Practice, ResEcon Life Sciences & Healthcare, New York, NY |
Eric M. Baim
Partner Dovetail; Former VP, Head of Compliance, US, Shire, Boston, MA
|
Shuba Balasubramanian, MBA
Principal, Deloitte, Dallas, TX |
Susan Barsky, MS
Vice President, Corporate Compliance, Biocryst; Former Head, North America Compliance, United Therapeutics, Raleigh, NC |
Evan Bartell
Partner, Risk Consulting, KPMG, New York, NY
|
Rachel Batykefer
VP, CIA and Compliance Operations, Mallinckrodt Pharmaceuticals, Bridgewater, NJ |
Ann Beasley, JD
Managing Director, Life Sciences Consulting Group, Paul Hastings; Former Senior Vice President and Chief Compliance Officer, Zai Lab, Boston, MA |
Amy Bentsen, JD
McDermott Will & Emery, Atlanta, GA
|
William Benvenuto, JD
SVP, Chief Legal Affairs, Compliance & Privacy Officer, Travere; Former Assistant GC & CCO, Millennium Health, San Diego, CA |
David Berger, JD
Senior Managing Director and Life Sciences Practice Lead, Ankura, New York, NY |
Matthew Berkle, JD, LLM
Member, Berkle Consulting LLC; Former Vice President, General Counsel, Head of Ethics and Compliance, Breckenridge Pharmaceutical, Inc., Roseland, NJ
|
Tracy Berns, JD
Senior Vice President, Chief Compliance & Quality Officer, Ionis Pharmaceuticals, Inc.; Former Chief Compliance Officer, Akcea Therapeutics, Boston, MA |
Richard T. Bistrong, MA
CEO, Front-Line Anti-Bribery LLC; Market Development Consultant, LRN, New York, NY |
Brian A. Bohnenkamp, MHA, JD
Partner, FDA & Life Sciences Practice, King & Spalding, Washington, DC
|
Eric Bolesh
Chief Operating Officer, Cutting Edge Information, Durham, NC |
Ryan Bonistalli, JD
Senior Director, Compliance, Ultragenyx; Former Director, Corporate Compliance, Kaleo, San Francisco, CA |
Jennifer Bragg, JD
Partner, Latham & Watkins; Former Associate Chief Counsel for Enforcement, Office of Chief Counsel, US FDA, Washington, DC
|
Lindsay Breedlove, JD
Senior Director, Head of Litigation & Investigations and North American Regulatory Counsel, Ultragenyx Pharmaceutical, San Francisco, CA |
Peter Brensilver, JD, MPH
Senior Vice President, Chief Global Commercial Compliance & Risk Counsel, Pfizer, New York, NY |
Noah Broestl, MS
Partner & Associate Director of Responsible AI, Boston Consulting Group, Brooklyn, NY
|
Alfred R. Brunetti, JD
Principal, Porzio, Bromberg & Newman; Former Assistant Prosecutor, Union County Prosecutor's Office, Morristown, NJ |
Eve M. Brunts, JD, LLM
Partner, Ropes & Gray, Boston, MA |
Terra Buckley, JD
Chief Compliance Officer, LivaNova; Former Executive Director, Head, US Healthcare Compliance, Celgene, Summit, NJ
|
Sri Burra, MBA
Director, US Ethics and Compliance, Organon; Former Ethics & Compliance Lead, North America, Haleon; Former Transformation Lead, Ethics & Compliance Workstream, GSK, Malvern, PA |
Briana Cabrera, MS, CFE
Senior Director, Global Compliance Investigations and Compliance Officer, Mechanical Circulatory Support, Medtronic, Miami, FL |
Parth Chanda, MPA, JD
Founder & CEO, Lextegrity; Former Chief Compliance Counsel - Global Oncology, Pfizer, New York, NY
|
Andrew Clark, MBA
Partner/Principal, Forensic & Integrity Services, EY, Washington, DC |
Yvonne Clark, JD
Vice President, Head of Corporate Compliance, Spark Therapeutics; Former Commercial Counsel, Merck, Philadelphia, PA |
Daniel Clifford, MBA
Board Network Leader, EY Center for Board Matters, Americas, EY, Dallas, TX
|
Chris Cobourn, MS
Managing Director GP Practice Lead, HELIO, Placida, FL |
Steven Cohen, MBA
Vice President & Chief Ethics and Compliance Officer, North America and Canada, Eli Lilly, Indianapolis, IN |
Jessica Colón, JD, MPH, CHC
Vice President, Associate General Counsel, Chief Compliance & Privacy Officer, West Pharmaceutical Services, Inc., Exton, PA
|
Chris Corallo
Deputy Chief Compliance Officer, Convatec, Bridgewater, NJ |
Luna Corbetta, MBA
Partner, Organization & Workforce Transformation, PwC; Former VP, Head of Marketing & Sales Operations, Bayer, New York, NY |
Thomas E. Costa, JD
Member, US Board of Directors, Sanofi; Former Vice President, US Compliance & Ethics, Bristol Myers Squibb, Morrisville, PA
|
David Cromley, JD
Principal, Cromley Consulting, LLC; Adjunct Professor, Villanova University Charles Widger School of Law, Glenside, PA |
Meenakshi Datta, JD
Partner and Global Co-leader, Healthcare Practice, Sidley Austin, Chicago, IL |
Mahnu V. Davar, MA, JD
Partner and Co-chair, Life Sciences & Healthcare Regulatory, Arnold & Porter, Washington, DC
|
Adriana Davies, JSM
VP, Compliance & Data Privacy, Smith & Nephew; Former Senior Compliance Director MITG, Medtronic, Jacksonville, FL |
James M. Dawson
VP, Compliance Solutions, Qordata; Former VP & CCO, United Therapeutics, Carrboro, NC |
Manya Deehr, JD
Founder and Principal, Deehr Law LLC, Newtown, PA
|
Audrey DeGuarde, MSJ
Vice President, Customer Success & Compliance Operations, RLDatix Life Sciences, Morristown, NJ |
Gary Del Vecchio
Health Care Compliance Officer Global Medical Affairs, Data Sciences, Johnson & Johnson, Titusville, NJ |
Gregory Demske, JD
Partner, Goodwin Procter; Former Chief Counsel, HHS Office of Inspector General, Washington, DC
|
Sarah diFrancesca, JD
Executive Director Compliance, Dermatology, Incyte, Wilmington, DE |
Donald DiLanno, MBA
Director of Global Healthcare Compliance, Insmed; Former Senior Manager, Compliance, Mallinckrodt, Lebanon, NJ |
Stefanie A. Doebler, JD
Partner and Co-Chair, Health Care Practice Group, Covington & Burling, LLP, Washington, DC
|
S. Joy Dowdle, JD
Partner, Paul Hastings, Houston, TX |
Isabel Duffy, JD
Senior Vice President, Chief Ethics and Compliance Officer; Former Associate General Counsel, Auxilium Pharmaceuticals, Merck, Wayne, PA |
Avia M. Dunn, JD, MBA
Partner, Life Sciences and Health Care, Skadden, Arps, Slate, Meagher & Flom, Washington, DC
|
Kip Ebel, MBA
Principal, Forensic & Integrity Services, EY, New York, NY |
Jacob T. Elberg, JD
Director, Center for Pharma Law, Seton Hall School of Law; Former AUSA, US Attorney's Office, District of New Jersey, Newark, NJ |
Aurelie Ercoli, LLM, PhD
Partner, White-Collar, Investigations and Government Enforcement Practice Group, DLA Piper, Washington, DC
|
Kevin L. Espinoza, MBA, JD
Vice President, Deputy Compliance Officer, Global Sanctions Officer, Indivior Inc., Richmond, VA |
Andrea Falcione, JD, CCEP
Chief Ethics & Compliance Officer & Head of Advisory Services, Rethink Compliance, Boston, MA |
David Falcone
VP Global Compliance, Merz Aesthetics; Former Director, Privacy, Ethics & University Compliance Officer, Duke University, Raleigh, NC
|
Alishia G. Farr, MJ
Senior Manager, Global Compliance Risk Evaluation and Mitigation, Convatec, Atlanta, GA |
Ronnie Feldman
Founder, CEO & Creative Director, L&E: Comedians Who Know Compliance; Former Head, Second City’s Comedic, Ethics, and Compliance Video Series, RealBiz Shorts, Chicago, IL |
Margaret K. Feltz, MA, JD
Vice President, Ethics & Compliance, CCO, Purdue Pharma LP; Former Co-chair, PCF, Stamford, CT
|
Alison Fethke, JD
Counsel, Ropes & Gray; Former Division Counsel, Legal Regulatory & Compliance AbbVie, Chicago, IL |
David Fisher, MS
President & Chief Operating Officer, TD International, Washington, DC |
Maya P. Florence, JD
Partner, Life Sciences and Health Care, Skadden, Arps, Slate, Meager & Flom, Boston, MA
|
Sara K. Frank, JD
Principal, Choate Hall & Stewart, Boston, MA |
Sarah A. Franklin, JD
Partner & Vice-Chair, Life Sciences Investigations, Covington & Burling, LLP; Former Attorney, US FTC, Washington, DC |
Paul S. Gadiock, JD
Partner, McDermott Will & Emery; Former Assoc Center Director, FDA Center for Devices and Radiological Health, San Franciso, CA
|
Abhiroop Gandhi, MBA
VP, Compliance, Rigel Pharmaceuticals; Former Trust & Compliance Officer, Verily (Google Life Sciences), San Francisco, CA |
Dana Garbo, MS, JD
Chief Privacy Officer, Medline Industries, LP; Former Privacy Lead, Embecta Spin-off (Diabetes Care business unit, BD), Northfield, IL |
Nereyda Garcia, JD
Head, Ethics & Compliance, US Business Unit, Takeda; Former Compliance Head, Rare Disease & Rare Blood Disorders, Sanofi, Boston, MA
|
Gary F. Giampetruzzi, JD
Partner & Global Chair Life Sciences Department, Paul Hastings; Former VP, Assistant General Counsel, Pfizer, New York, NY |
Gejaa T. Gobena, JD
Partner, Hogan Lovells; Former Deputy Chief, Fraud Section, Criminal Division, US Department of Justice, Washington, DC |
Baris Goc
Partner, Life Sciences Risk Consulting Team, PwC, New York, NY
|
Kate Godfrey, JD, CCEP
Senior Vice President, Global Chief Compliance Officer, Chief Compliance Officer, Karl Storz, US, Seattle, WA |
Christine Gordon, JD
CCO & Head of GRC; Governance, Risk & Compliance Function, Olympus, Bethlehem, PA |
Audriana "Audi" Grant
Senior Manager, Monitoring & Auditing, Ethics, Compliance & Privacy, Plainsboro, NJ
|
Nancy Grygiel, LLM
SVP & CCO, Amgen; Former VP Compliance, Corporate and International, Allergan, Newbury Park, CA |
Jaime Guerrero, JD
VP, Global Compliance, Edwards; Former AUSA, United States Attorneys' Office, Central District of California, Irvine, CA |
Kris Hall, JD, CIPP/CIPM
Managing Director, Dovetail Consulting Group; Former VP, Chief Privacy Officer, Celgene, Bridgton, ME
|
Margaux Hall, JD
Partner, Partner, Ropes & Gray, Washington, DC |
Laura Hamm
Director, Ethics and Compliance, Esperion; Former Senior Director, Corporate Compliance, Aimmune Therapeutics, San Jose, CA |
Kassie Harrold, JD
EVP & CCO, Integrity & Compliance, Mallinckrodt; Former Global Compliance Counsel, Solutia, St. Louis, MO
|
Nevada Heft, JD
Global Privacy Director, Merck, Upper Gwyneed, PA |
Julia Heller
Principal, Global Commercial Compliance Consulting, US Leader, IQVIA, Philadelphia, PA |
Saul B. Helman, MD, MBA
President, Epsilon Life Sciences, Chicago, IL
|
Nancy Henshaw
Regulatory Lead, RLDatix Life Sciences, Morristown, NJ |
Michael G. Hercz, JD
Senior Vice President General Counsel and Chief Compliance Officer, Sentynl, Los Angeles, CA |
Laura E. Heyduk
Head, US Compliance, Biogen; Former Compliance Director, Insulet, Cambridge, MA
|
|
|
|
|
|
UPDATED AGENDA NOW AVAILABLE
|
Click here for updated Agenda.
|
|
CONGRESS HOTEL DISCOUNTED GUEST ROOM BLOCK IS SOLD OUT. CONVENIENT OVERFLOW HOTELS AVAILABLE. CLICK HERE FOR ALTERNATIVES.
|
|
|
SPONSORED BY
|
|
|
PRODUCED BY
|
|
|
PCF BOARD
|
Donna White, CCEP
Vice President and Compliance Officer, Chiesi (Board Chair)
Christie Camelio
Senior Vice President and Chief Compliance Officer, Insmed (Board Secretary)
Jill Dailey, JD
Vice President & Chief Compliance Officer, Incyte (Board Treasurer)
Cindy Cetani, LPEC, NACD.DC®
Chief Integrity and Compliance Officer, Indivior
Anisa Dhalla
Vice President and Chief Ethics and Compliance Officer, UCB
Daryl Kreml, JD
Senior Vice President, Chief Enterprise Risk and Compliance Officer, Sage Therapeutics
|
|
MEDICAL DEVICE EXECUTIVE COMMITTEE
|
Michael R. Clarke, JD, CCEP
VP, Global CCO, ConvaTec
Sujata Dayal, JD
Independent Board Director, Emergent; BioSolutions; Senior Advisor, Ethicist International
Tara Shewchuk, JD
Global Chief Ethics & Compliance Officer, Medtronic
Daniel Spicehandler, JD
Vice President Compliance, Commercial Divisions, Stryker
|
|
GRANTORS
|
|
PLATINUM
|
|
|
GOLD
|
|
|
SILVER
|
|
|
BRONZE
|
|
|
MEDIA PARTNERS
|
|
|
CONTINUING EDUCATION CREDITS & CERTIFICATE OF ATTENDANCE
|
Compliance Certification Board (CCB)®
This education activity has been submitted to the Compliance Certification Board (CCB)® and is currently pending their review for approval of CCB CEUs.
Continuing Legal Education
The Pharmaceutical and Medical Device Ethics and Compliance Congress has been approved to offer 23 Live and 18 e-learning Pennsylvania CLE Credits.
To qualify for CLE credits, you must (1) pay $100 ands (2) complete and submit the Pharma Congress Continuing Education Credit Self Reporting and Evaluation Form.
Certificates of Attendance.
Attendees may download and self-complete a certificate of attendance which will be posted on the Congress virtual video broadcast platform to file with appropriate certifying bodies which accept such.
|
|
TUITION SCHOLARSHIPS
|
The Pharma & Medical Device Congress is now offering a limited number of partial and full Tuition Scholarships to qualifying representatives of government, consumer advocate organizations, academics, students, representatives of health services research organizations, and those in employment transition.
Click here for more information.
|
|
TWEET (X)
|
@pharmacongress
#pharmacongress
|
|
Tom Hiney, JD, CIPP/US, CIPM
Senior Director, Blueprint Medicines, Boston, MA |
Howard Holloway
Global Governance Lead, Global Medical Affairs & Governance, Patient Oriented Programs, Novartis, Zurich, Switzerland |
Miranda Hooker, JD
Partner, Goodwin Procter LLP; Former Assistant United States Attorney, United States Attorney's Office, District of Massachusetts, US Department of Justice, Boston, MA |
Zach Hornsby, JD
Chief Ethics & Compliance Officer B. Braun of America, B. Braun Medical Inc.; Former Chief Business Integrity & Responsibility Officer, Technology Enabled Services, Change Healthcare, Atlanta, GA |
Casey J. Horton, CFE
Managing Director, Epsilon Life Sciences; Former Director, Compliance Operations, AbbVie, Chicago, IL
|
Peter Jensen, JD
Vice President, Global Chief Compliance Officer, Arthrex, Naples, FL |
Elizabeth Jobes, LLM
Global Chief Compliance Officer, Immunocore; Board, Blue Foundry Bank, Ampio Pharmaceuticals, Inc., and Eyam Vaccines and Immunotherapeutics, Philadelphia, PA |
Amanda Johnston, JD
Managing Attorney, Gardner Law, PLLC; Adjunct Professor of Law, Mitchell Hamline School of Law, St. Paul, MN |
Erin Brown Jones, MA, JD
Deputy Office Managing Partner, Washington DC, Latham & Watkins LLP, Washington, DC |
Catherine Kanzler, JD
Vice President, Global Head, GRC Strategy & Planning, Olympus Corporation, Cedar Valley, PA
|
Salman Kasbati
Chief Operating Officer, Qordata; Former Associate Partner, Streebo |
Melissa Kaschak, CPA, CFE, CISA
Compliance Operations and ERM, Olympus Corporation of the Americas, Allentown, PA |
Rim El Kassaby, LLM
Director US Business Counseling & Support, Organon, Dubai, UAE |
Jeffrey Kawalek, MBA
Chief Compliance Officer, Zambon US; Former Deputy Chief Compliance Officer US, Jazz Pharmaceuticals, New York, NY |
Joseph E. Keeney, JD
Head of Ethics and Compliance, Galderma Laboratories, Dallas, TX
|
Jonathon L. Kellerman
Global Chief Ethics, Compliance and Privacy Officer & Global Head of Business Transformation, Bausch + Lomb, Bridgewater, NJ |
Kiley Smith Kelly, MBA
Partner/Principal, Forensic & Integrity Services, EY, Philadelphia, PA |
Saad Khan
Head of Compliance, US Respiratory & Immunology, AstraZeneca; Former Operational Compliance Lead, Business Risk & Compliance (Finance), GSK, Philadelphia, PA |
Quinton Kinne, CCEP, CFE
Associate Director, Patient Engagement & Customer Solutions, Johnson & Johnson Innovative Medicine, Horsham, PA |
Kristin Graham Koehler, JD
Office Managing Partner, Washington DC Office, Management Committee, and Executive Committee Member, Sidley Austin LLP, Washington, DC
|
Amy D. Kossak, JD
Partner, Ropes & Gray; Former Senior Trial Counsel, US Department of Justice, Washington, DC |
Olivia Krzeminski, JD
Associate Director Compliance, G&M Health |
Kim Kwak
Director, Global Corporate and Healthcare Compliance, Medline Industries; Former Associate Director, AbbVie, Cincinnati, OH |
Angelique Lee, JD
VP, CCO & Ethics Officer, Jazz Pharmaceuticals; Former VP & CCO, Greenwich, Orange County, CA |
Peter Lee, JD
Vice President Compliance, Mirati Therapeutics; Former CCO, Provention Bio & Heron Therapeutics, San Diego, CA
|
Terri L. Ledva, MS
Director, Ethics & Compliance, Aurobindo, Philadelphia, PA |
Gerard Leeman
Senior Director, Compliance, Ono Pharma; Former Global Head of Compliance, Life Science and Performance Materials, Merck KGaA, Cambridge, MA |
Henry C. Leventis, JD
Partner, Healthcare Regulatory & Enforcement, Holland & Knight; Former United States Attorney, US Attorney's Office, Middle District of Tennessee, US Department of Justice, Nashville, TN |
Scott S. Liebman, JD
Partner, Chair of FDA Regulatory & Compliance, Co-Chair of Life Sciences Practice, Sheppard Mullin Richter & Hampton LLP, New York, NY |
Victoria A. Lipnic, JD
Partner, Head of Human Capital, ResEcon Life Sciences & Healthcare; Former Commissioner & Acting Chair, US EEOC, Washington, DC
|
Cristina List, CPA, CCEP
Director, Compliance Advisory Services, MedPro Systems; Former Compliance Officer, Carestream, Mount Arlington, NJ |
Kirsten Liston
Principal & Founder, Rethink Compliance; Co-author, The Compliance Entrepreneur's Handbook, Denver, CO |
Brian Long, MBA
Partner, Health Industries Risk & Regulatory, PwC, Chicago, IL |
Timothy P. Loper, JD
VP, Head of US & Above Market Compliance & Ethics, Bristol Myers Squibb; Former AUSA, US Attorney's Offices, Washington, DC & Miami, FL, US DOJ, Princeton, NJ |
Paul H. Luehr, JD
Partner, Privacy and Data Security, Manatt, Washington, DC
|
Seth H. Lundy, JD
Partner, FDA and Life Sciences, King & Spalding, Washington, DC |
Traci Maldonado
Senior Manager, Ethics & Compliance Training, Policy & Communications, Ethics & Compliance, Novo Nordisk, Lebanon, NJ |
Jim Massey, MS
Advisor/Consultant to Executives, Founders, C-suite, Board Directors, ROUTE 2 INC; Board Member One Tree Planted, Washington DC |
Elaina McEwan
Director, Life Sciences Consulting Group, Litigation Department, Paul Hastings, New York, NY |
Rosemary McKenna, JD
Executive Director, Regulatory Legal, Organon; Former Director, Regulatory Legal, Merck, Philadelphia, PA
|
Jenny McVey, MS, PhD
North America Compliance Officer, bioMérieux; Adjunct Professor, Fordham University School of Law, Salt Lake City, UT |
Allan Medina, JD
Partner, Goodwin Procter LLP; Former Senior Deputy Chief, Criminal Division US Department of Justice, Washington, DC |
Robert Melillo, JD
Co-founder & Managing Director, G&M Health; Former VP, PRS Franklin, Frenchtown, NJ |
Scott A. Memmott, JD
Partner, Morgan, Lewis & Bockius LLP; Former Special Assistant US Attorney, Eastern District of Virginia, Washington, DC |
Shannon Moesaa, JD
Former VP Commercial & Healthcare Compliance Counsel, Karuna; Former Assistant GC, Arena Pharma, Boston, MA
|
Mike Morgan, MBA
Global Compliance Officer, Telix Pharmaceuticals; Former Ethics and Compliance Officer, North America, Corteva, Indianapolis, IN |
Gregory S. Moss, LLB
Chief Business & Legal Officer, Corporate Secretary & CCO, Evommune, Inc., New York, NY |
Christine A. Moundas, MPH, JD
Partner, Ropes & Gray, LLP; Former Analyst, HHS, New York, NY |
Jared P. Nagley, JD
Partner, Sheppard Mullin Richter & Hampton LLP; Former Attorney, FTC, New York, NY |
Brooke Nelson, JD
VP, Ethics & Business Integrity, North America & Global Specialty Care, Sanofi, Boston, MA
|
Katherine C. Norris, MPA
Senior Managing Director, Ankura, Honolulu, HI |
Daniel O'Connor
SVP, NXLevel Compliance; Former VP, Learning & Development, Morgan Stanley, New York, NY |
Adam Oakley
Senior Director, Potomac River Partners, Washington, DC |
John Oroho, JD
Senior Advisor, Global Life Sciences - RLDatix Life Sciences; Of Counsel, Porzio, Bromberg & Newman, Morristown, NJ |
Gus Papandrikos, MBA
Global Head of Compliance Assurance, Daiichi Sankyo; Former Senior Head, Compliance Operations, Shire, New York, NY
|
Garrett Pape, JD
Principal, Forensic & Integrity Services, EY, Chicago, IL |
Mark Pearson, MBA
Principal, Deloitte, Chicago, IL |
Danielle Pelot, JD
Partner, Choate Hall & Stewart, Boston, MA |
James Perkins, JD, MBA/MS
Compliance Officer, Medtronic; Former VP Client Management, UnitedHealth Group, Nashville, TN |
Kristen Perriello, JD
Principal, Choate, Hall & Stewart, LLP, Boston, MA
|
Patricia Petit, MBA
Executive Director, Compliance Officer, Olympus Corporation of the Americas, Miami, FL |
Erica Powers
Head, US Commercial Compliance & Compliance Operations, Sage; Former Director Corporate Compliance, Vertex, Boston, MA |
Hannah Putnam, MHA, CHC, CHRC
Senior Director, Ethics & Compliance, Veloxis Pharmaceuticals, Inc.; Former Senior Ethics & Compliance Officer, Fresenius Medical Care's Renal Therapies Group, Cary, NC |
Lori Queisser
President, Queisser and Associates; Fromer SVP & Global CCO, Teva; Former Member, PCF Executive Committee, Syracuse, IN |
John S. Rah, JD
Counsel, Potter & Murdock, Potomac, MD
|
David Ralston, JD
Managed Care Attorney Consultant; Market Access Legal Specialist, Biogen and Rocket Pharmaceuticals, Boston, MA |
Arun G. Rao, JD
Partner, Global Investigation and White-Collar Defense, Mater Broen (As of 10/28/24); Former Deputy Assistant Attorney General, Consumer Protection Branch, US Department of Justice, Washington, DC |
James (Jamie) Ravitz, JD
Partner and Co-head, Life Sciences Industry Practice and Head, FDA Practice, McDermott Will & Emery, Washington, DC |
Nikki Reeves, JD
Partner & Co-chair, Life Sciences & Healthcare Industry Group, King & Spalding, Washington, DC |
Michael Reyes
Senior Manager - Health Industries Risk & Regulatory Consulting, PwC; Former Analyst, Compliance Analytics, Edwards Lifesciences, Dallas, TX
|
Brian Riewerts
Principal, Pharmaceutical and Life Sciences, Cyber Risk and Regulatory Leader, PwC, Washington, DC |
Ashley Riley, JD
Head of Compliance, North American & New Markets, BeiGene, Ltd., Charlotte, NC |
Timothy Roberts, MA
Global Chief Compliance Officer, Legend Biotech; Former Senior Director Compliance & Privacy U.S, Ferring, Mendham, NJ |
Theodore Roselund
Managing Director & Senior Partner and Former Chief Risk Officer, The Boston Consulting Group, Montclair, NJ |
Patrick Santiago, MBA, CIPM
Director, Global Data Privacy, Genmab; Former Associate Director, U.S. Data Privacy Operations, Boehringer Ingelheim, Plainsboro, NJ
|
Elan Schefflein, JD
Senior Compliance Advisor, MedPro Systems, New York, NY |
Mara Senn, JD
Executive Global Compliance Lead, Investigations, Monitoring & Transparency (IMT), GE HealthCare, Piscataway Township, NJ |
Terri Segura, JD
Vice President, Compliance Officer, Americas, Zimmer Biomet |
Linda Severin, JD
Managing Member, Whistleblower Law Collaborative LLC; Former Assistant US Attorney, Southern District of New York, Boston, MA |
Sulin Shah, JD
Law Offices of Sulin Shah; Legal Consultant, Soleno Therapeutics; Former VP, US GC, PharmaEssentia, Chicago, IL
|
John Shakow, JD
Partner, King & Spalding LLP, Washington, DC |
Gregg Shapiro, JD
Founder, Gregg Shapiro Law; Former Assistant US Attorney, US Attorney's Office, District of Massachusetts, DOJ, Boston, MA |
Alexis Shaw
Deputy Chief Compliance Officer, Paratek Pharmaceuticals; Former Compliance Officer, Endo, King of Prussia, PA |
Michael L. Shaw, JD
Global Head, Compliance, Privacy & Risk, ZS; Former VP & CO, GlaxoSmithKline; Former Senior Counsel, HHS OIG, Princeton, NJ |
Paul Silver
Corporate Intelligence Services Practice Leader, Life Sciences Regulatory, Legal, & Compliance Leader, Deloitte Advisory, Atlanta, GA
|
Sara R. Simon, JD
Counsel, Porzio, Bromberg & Newman; Former Director, US Health Care Compliance Certification Program, Seton Hall, Morristown, NJ |
Sameer Singh, JD
Director, Risk Consulting, KPMG LLP, New York, NY |
Laura A. Skinner, MBA
Managing Director, Life Sciences Consulting Group, Paul Hastings, New York, NY |
Ed Sleeper, MS
VP, Chief Ethics and Compliance Officer, Veloxis; Former Global Chief Ethics and Compliance Officer, HUTCHMED, Cary, NC |
Mike Stanek, JD
Associate Vice President, Assistant General Counsel, Eli Lilly and Company, Indianapolis, IN
|
Juan Diego Alonso Succar, MBA, JD
Director, Ethics & Compliance, Purdue Pharma LP, Stamford, CT |
Eric Teasdale, JD
Senior Director, US Business Ethics Global Business Ethics, Ipsen; Former Head, USBU Ethics & Compliance, Takeda, Cambridge, MA |
Keren Tenenbaum, JD
Chief Compliance Officer, Zoetis; Former US GC & CCO, New York, NY |
Kelly J. Tope, JD, MBA
Head, USBU Ethics & Compliance Monitoring & Reporting Operations, Takeda, Boston, MA |
Natasha Trifun, JD
Executive Director, Head of Compliance, R&D, Global Medical, Alexion, AstraZeneca Rare Disease, Boston, MA
|
Jonathan Turner, MSc
Chief Compliance & Privacy Officer, ZOLL Medical Corporation, Pittsburgh, PA |
Manny Tzavlakis
Managing Partner, HELIO, Morristown, NJ |
Erin Vales
Principal Consultant, Cresen Solutions, Richmond, VA |
Steve Vincze, JD, MBA
CEO, TRESTLE; Former SVP & CCO, Warner Chilcot; Former VP, Ethics & Compliance, TAP, Boston, MA |
Matt Wetzel, JD
Partner, Life Sciences & MedTech Group, Goodwin Procter LLP, Washington, DC
|
Seth Whitelaw, JD
President and Chief Executive Officer, Whitelaw Compliance Group, Philadelphia, PA |
Constance A. Wilkinson, JD
Board of Directors, Member of the Firm, Epstein Becker & Green, P.C., Washington, DC |
Susan Williamson, MBA
Senior Vice President & Chief Compliance Officer, Endo, Malvern, PA |
Amy Wilson, MBA, MSJ
Vice President, Chief Compliance Officer, Esperion; Former Head of U.S. Compliance, MorphoSys, Boston, MA |
Tyler Wiseman, MBA, JD
Chief Legal Officer, Elevar Therapeutics; Former Corporate Counsel, Praxis Precision Medicines, Boston, MA
|
Ronald L. Wisor, Jr, JD
Partner, Lifesciences & Healthcare, Hogan Lovells, Washington, DC |
Heather Young, JD
Executive Director, Compliance Officer, Olympus Corporation of the Americas; Former AUSA, US Attorney's Office, District of Philadelphia, Center Valley, PA
|
|
CONGRESS EXHIBIT & SPONSORSHIP INFORMATION
|
|
For sponsorship and exhibit information contact Sarah Grosse, Exhibit & Sponsorship Coordinator, at (206) 244-4861 phone, (206) 319-5303 fax, or exhibits@hcconferences.com.
|
|
FOR E-MAIL ADDRESS CHANGE, ADD OR DELETE REQUESTS
|
For changes or additions, please email your request to: listmgr@PharmaUpdateNewsService.com.
For removal of your e-mail address, please click the link below for "SafeUnsubscribe" to automatically remove your address from the list.
|
|
|
|
|
